- Home
- HIX vs TKNO Comparison
HIX vs TKNO Comparison
Compare HIX & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIX
- TKNO
- Stock Information
- Founded
- HIX 1998
- TKNO 1996
- Country
- HIX United States
- TKNO United States
- Employees
- HIX N/A
- TKNO N/A
- Industry
- HIX Finance/Investors Services
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- HIX Finance
- TKNO Health Care
- Exchange
- HIX Nasdaq
- TKNO Nasdaq
- Market Cap
- HIX 391.7M
- TKNO 356.4M
- IPO Year
- HIX N/A
- TKNO 2021
- Fundamental
- Price
- HIX $4.27
- TKNO $4.23
- Analyst Decision
- HIX
- TKNO
- Analyst Count
- HIX 0
- TKNO 0
- Target Price
- HIX N/A
- TKNO N/A
- AVG Volume (30 Days)
- HIX 449.5K
- TKNO 336.8K
- Earning Date
- HIX 01-01-0001
- TKNO 08-07-2025
- Dividend Yield
- HIX 13.14%
- TKNO N/A
- EPS Growth
- HIX N/A
- TKNO N/A
- EPS
- HIX N/A
- TKNO N/A
- Revenue
- HIX N/A
- TKNO $38,923,000.00
- Revenue This Year
- HIX N/A
- TKNO $8.73
- Revenue Next Year
- HIX N/A
- TKNO $16.53
- P/E Ratio
- HIX N/A
- TKNO N/A
- Revenue Growth
- HIX N/A
- TKNO 11.40
- 52 Week Low
- HIX $4.16
- TKNO $3.45
- 52 Week High
- HIX $5.08
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- HIX 50.93
- TKNO 37.62
- Support Level
- HIX $4.21
- TKNO $4.03
- Resistance Level
- HIX $4.28
- TKNO $4.48
- Average True Range (ATR)
- HIX 0.03
- TKNO 0.43
- MACD
- HIX -0.00
- TKNO -0.02
- Stochastic Oscillator
- HIX 57.73
- TKNO 13.79
About HIX Western Asset High Income Fund II Inc.
Western Asset High Income Fund II Inc is a diversified closed-end management investment company. Its investment objective is to maximize current income by investing at least 80% of its net assets and borrowings for investment purposes in high-yield debt securities.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.